AKT1 and cancer: Furthermore, in vitro experiments revealed that the effect of NEDD4L knockdown on cancer cell proliferation was reversed by treatment with rapamycin, a selective mTOR inhibitor that suppresses the AKT/mTOR signaling pathway (Figure 2K; Figure S4G, Supporting Information).